Dr. Maria Ryan and Dirk Gieselman introduce new technologies to detect and reduce risk factors: From aMMP8 diagnostic, to biofilm reduction for Implants and anti-inflammatory therapy.
Recent meta analysis reported an association between Periodontal disease (PD) and coronary heart disease (CHD) and show a significant higher risk of 1.14 to 2.22 of developing (CHD).
The new chair-side of detection of matrix metalloproteinase MMP8 allows clinicians to monitor periodontal disease status in a site-specific manner and increase the patient compliance to treatment option and relevance to general health and CHD.
The consensus Report of the sixth European Workshop on Periodontology showed that Periimplantitis occurs in 28%-56% of subjects and becomes a major problem to implant dentistry in the future. Current evidence indicates that most of destruction of the periodontium is host mediated, driven by bacterial challenge.
Zirconium nitride hard coating technology for dental implants showed a high significant positive effect on biofilm reduction and fibroblast adhesion and surface mechanical resistance.
The speaker will answer your questions
There are no commnets, questions or opinions posted yet. Be the first to comment on this course, it's easy! Just use the box below to write your message and the click "Post"
Dirk-Rolf Gieselmann, CEO, Clinical House Europe GmbH
Dirk-Rolf Gieselmann – CEO: Dirk-Rolf Gieselmann served in the medical device sector for over 20 years. After studying dental technology at the CUNO Technical High school he became chief laboratory manager at the university school of dentistry Witten/Herdecke. To extend his knowledge in aesthetic reconstructions and orthodontics Dirk worked as a assistant laboratory manager at the creative dental ceramics Beverly Hills Medical Center and at the Duringer Orthodontic laboratory Alameda, CA. In 1991 Dirk started his career in medical sales management at the Dental Implant Market Leader STRAUMANN. While he was working for Straumann as a regional sales manager he completed his business education and past several diploma programs (Marketing Management, Sankt Gallen School of business, Finance, Kellogs Graduate School of Management). To extend his management skills Dirk did work part time in a consultancy as associated partner for almost three years. In 1995 he started his executive career being responsible for the build up of the 3i organisation in Germany. Dirk shortly became General Manager and grew the business from 0 to over 20 Mio. DM within three years. Dirk than took up the responsibility for the start up organisation for ALIGN Technology in Germany, Switzerland and Austria and built the market for the invisible braces technology. Within 12 month the ALIGN company was market leader in this business and generated over 7 MIO € in the first year of operations. In 2002 Dirk became General Manager of MATHYS Osteosynthese GmbH , he reorganised the business and managed a buy-out process of the 70 Mio€ business successfully. Since 2006 Dirk is working for Clinical House Europe GmbH with the main goal to identify new business opportunities and starting up new business ventures and building a future player in the Dental Implant market.
Maria Emanuel Ryan, DDS, PhD
Dr. Maria Emanuel Ryan, a 1989 Stony Brook School of Dental Medicine graduate, is a tenured full Professor in the Department of Oral Biology and Pathology at the School of Dental Medicine and a member of the Medical Staff at University Hospital at Stony Brook University Medical Center. She also serves as the Associate Dean for Strategic Planning and External Affairs as well as the Director of Clinical Research.
Dr. Ryan received her specialty training in periodontics at the University of Connecticut Health Center, and her Ph.D in Oral Biology and Pathology at Stony Brook. Dr. Ryan is actively involved in teaching, practice and research at the School of Dental Medicine. Dr. Ryan serves on several scientific, dental and medical advisory boards.
In 1996 Dr. Ryan was the recipient of the New Dentist Leadership Award from the Dental Society of the State of New York. In addition, she received an achievement award from the American Dental Association in 1997, followed by induction into the Long Island Academy of Odontology in 1999 and the honor society Omicron Kappa Upsilon in 2003. Dr. Ryan was a Fellow of the Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Program for Women at Drexel University College of Medicine. She is a nationally and internationally known speaker and author and has published over 75 original scholarly works. Dr. Ryan's research is funded by the National Institutes of Health, private foundations and industrial sources. She holds several U.S. patents based on her work at the University.
Dr. Ryan lectures frequently and has appeared on CNN, Americas Health Network, NBC, CNBC, ABC and NPR to discuss newly emerging therapeutics, the connections between oral and systemic health and the need for early detection of periodontal disease and oral cancer. She has been an invited speaker at the Centers for Disease Control, the Juvenile Diabetes Foundation, the American Diabetes Association, the American Dental Association, the American Academy of Periodontology, the National Periodontal Disease Coalition of Oral Health in America and the National Institutes of Health to discuss the role of the dental professional in the provision of optimal overall health care, with a special emphasis on issues specific to the management of diabetes.
Dr. Ryan is the Past President of the Stony Brook University Alumni Association. She recently served on the Presidential Search Committee for Stony Brook University. She also serves as a member of The Science Advisory Council at Barnard College, Columbia University where she received her bachelor's degree. Dr. Ryan resides in Laurel Hollow, New York with her husband Dr. Charles Ryan and their son Peter.
This lecture will introduce new technologies to detect and reduce risk factors: From aMMP8 diagnostic, to biofilm reduction for Implants and
Most patients who have periodontitis respond to routine management, which can include scaling and root planning, periodontal flap surgery (r
Dr. Lai reviews issues related to the treatment of gingival recessions and gingival insufficiency including some new approaches being used a
When patients ask “What products should I use for better oral health?”, dental practitioners should be able to provide evidence based answer
Mucogingival surgery for correction of soft tissues within the oral cavity is a common procedure in dentistry.